Literature DB >> 22999561

Relationship of the location of the ventricular catheter tip and function of the ventriculoperitoneal shunt.

Shoko Merrit Yamada1, Ryo Kitagawa, Akira Teramoto.   

Abstract

The long-term maintenance of ventriculoperitoneal (VP) shunt function depends on the correct placement of the catheter tip in the lateral ventricle. The relationship between the location of the ventricular catheter tip and VP shunt function was analyzed in 52 patients. The location of the ventricular catheter tip was classified into one of the following five groups: (i) Group A--superior to the foramen of Monro; (ii) Group B--in the center of the lateral ventricle body; (iii) Group C--in the third ventricle; (iv) Group D--contacting the ventricle wall; and (v) Group E--in the septum pellucidum. VP shunt function was defined as well controlled hydrocephalus when the Evan's ratio of the ventricular size was < 0.3. The VP shunt functioned well in 14 of 52 patients (26.9%), the shunt valve pressure was incorrectly set in 21 (40.4%), and irreversible shunt malfunction was identified in 17 (32.7%). Among the 14 patients with a well-functioning shunt, 13 were in Groups A or B with an odds ratio (OR) of 17.875 (p<0.05). In the 17 irreversible shunt malfunctions, 13 were identified in Groups C, D, or E with an OR of 0.123 (p<0.05). Long term VP shunt function or failure due to irreversible malfunction is directly influenced by the position of the ventricular catheter tip. Ideal points for positioning the ventricular catheter tip are superior to the foramen of Monro and in the center of the lateral ventricle body. Early shunt revision may be required for patients in whom the catheter tip contacts the ventricle wall or is located in the septum pellucidum.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22999561     DOI: 10.1016/j.jocn.2012.01.041

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

1.  Computational Modeling and Simulation to Quantify the Effects of Obstructions on the Performance of Ventricular Catheters Used in Hydrocephalus Treatment.

Authors:  Stephanie TerMaath; Douglas Stefanski; James Killeffer
Journal:  Methods Mol Biol       Date:  2022

Review 2.  The effect of image-guided ventricular catheter placement on shunt failure: a systematic review and meta-analysis.

Authors:  Pietro Spennato; Francesca Vitulli; Nicola Onorini; Alessia Imperato; Giuseppe Mirone; Claudio Ruggiero; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2022-05-03       Impact factor: 1.532

3.  Structural deficits and cognitive impairment in tuberculous meningitis.

Authors:  Hsiu-Ling Chen; Cheng-Hsien Lu; Ching-Di Chang; Pei-Chin Chen; Meng-Hsiang Chen; Nai-Wen Hsu; Kun-Hsien Chou; Wei-Ming Lin; Ching-Po Lin; Wei-Che Lin
Journal:  BMC Infect Dis       Date:  2015-07-22       Impact factor: 3.090

4.  Guided Application of Ventricular Catheters (GAVCA)--multicentre study to compare the ventricular catheter position after use of a catheter guide versus freehand application: study protocol for a randomised trail.

Authors:  Andreas Schaumann; Ulrich-Wilhelm Thomale
Journal:  Trials       Date:  2013-12-12       Impact factor: 2.279

5.  An approach using the occipital parietal point for placement of ventriculoperitoneal catheters in adults.

Authors:  Jason Duong; Christopher J Elia; Dan Miulli; Fanglong Dong; Andrew Sumida
Journal:  Surg Neurol Int       Date:  2019-02-22

6.  GAVCA Study: Randomized, Multicenter Trial to Evaluate the Quality of Ventricular Catheter Placement with a Mobile Health Assisted Guidance Technique.

Authors:  Ulrich-Wilhelm Thomale; Andreas Schaumann; Florian Stockhammer; Henrik Giese; Dhani Schuster; Stefanie Kästner; Alexander Sebastian Ahmadi; Manolis Polemikos; Hans-Christoph Bock; Leonie Gölz; Johannes Lemcke; Elvis Hermann; Martin U Schuhmann; Thomas Beez; Michael Fritsch; Berk Orakcioglu; Peter Vajkoczy; Veit Rohde; Georg Bohner
Journal:  Neurosurgery       Date:  2018-08-01       Impact factor: 4.654

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.